Press Releases

SOLCO HEALTHCARE U.S. ANNOUNCES THE APPROVAL OF GENERIC CYMBALTA® CAPSULES IN THE UNITED STATES

Aug 21, 2017 15:10

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Cymbalta® Capsules (Duloxetine delayed-release capsules), 20mg, 30mg...

Read more

SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR TELMISARTAN TABLETS, 20mg, 40mg and 80mg.

Jun 08, 2017 00:00

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Telmisartan tablets, 20mg, 40mg and 80mg, which are AB-rated equivalents to Micardis® by Boehringer Ingelheim. “This recent...

Read more

SOLCO HEALTHCARE INTRODUCES OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE Tablets

Apr 24, 2017 00:00

CRANBURY, NJ -- Solco Healthcare today announced the launch of generic version of Daiichi-Sankyo’s Benicar-HCT®, Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20mg/12.5mg, 40/12.5mg and 40mg/25mg.  Solco received its final approval by...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2017 2016